Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Objective: Several small published case reports have suggested that selective serotonin reuptake inhibitors (SSRIs) can cause night sweats. The purpose of this study was to investigate this possibility further and to explore possible associations between night sweats and other commonly prescribed medications.
Design: Cross-sectional, secondary data analysis.
Setting: Data were obtained during the Oklahoma Longitudinal Assessment of the Health Outcomes of Mature Adults, a longitudinal cohort study carried out in the Oklahoma Physicians Resource/Research Network.
Participants: 413 adult primary care patients aged 65-94 years.
Interventions: Current regular use of one of 35 classes of medication.
Main Outcome Measures: At least moderate night sweats during the prior month.
Results: A total of 38 (9.2 %) reported night sweats. Age, gender, body mass index, and total number of medications taken regularly were not associated with night sweats. After adjusting for age and gender, SSRIs (odds ratio [OR] 3.01; 95 % confidence interval [CI] 1.26-7.19), angiotensin receptor blockers (ARBs) (OR 3.44; 95 % CI 1.36-8.69), and thyroid hormone supplements (OR 2.53; 95 % CI 1.24-5.15) were the only classes of medications associated with night sweats.
Conclusions: Use of SSRIs may well be associated with night sweats in older patients. Associations found between night sweats and ARBs and thyroid supplements warrant further study.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4883206 | PMC |
| http://dx.doi.org/10.1007/s40801-015-0007-8 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
An outbreak of acute pulmonary histoplasmosis after exposure to guano in a hollow tree in Ecuador.
Travel Med Infect Dis
September 2025
Infectious and Tropical Diseases Unit, Azienda Ospedale Università Padova, 35128, Padua, Italy; Department of Molecular Medicine, University of Padova, 35128, Padua, Italy.
Background: Outside of classic endemic areas, histoplasmosis has gained attention due to an increased incidence in immunocompetent travellers, attributable to changes in behaviours during travel.
Methods: A cluster of five patients who presented with acute pulmonary histoplasmosis after travelling to the Ecuadorian Amazon Region is described in this article.
Results: Five patients (four females and one male), all in their 20s, presented with acute pulmonary histoplasmosis between sixteen and twenty-three days after the potential airborne exposure after travelling to the Ecuadorian Amazon Region.
Cardiac tamponade as a rare presentation of Hodgkin's lymphoma: a case report.
Front Oncol
August 2025
Department of Paediatric Haematology and Oncology in Zabrze, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Zabrze, Poland.
Hodgkin's lymphoma usually manifests with symptoms such as enlarged peripheral lymph nodes, fever, night sweats, and weight loss. It's the third most common pediatric cancer and includes two main types. Here, we describe a case of a 17-year-old boy, whose one of the first signs of Hodgkin's lymphoma was cardiac tamponade.
View Article and Find Full Text PDFHIV-Associated Multicentric Castleman Disease with Kaposi Sarcoma: A Case Report with 120-Week Follow-Up of HHV-8 After Remission.
J Infect Chemother
September 2025
AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan; Center for AIDS Research, Kumamoto University, Kumamoto, Japan.
HIV-associated multicentric Castleman disease (HIV-MCD) is a rare, life-threatening lymphoproliferative disorder featuring systemic inflammation and marked lymphadenopathy. HIV-MCD is characterized by a human herpesvirus-8 (HHV-8) infection, with an increasing incidence despite advances in antiretroviral therapy (ART). Although HHV-8 viremia is a recognized indicator of disease recurrence, the necessity of intervention for low-level viremia reactivation remains unclear.
View Article and Find Full Text PDFPrimary Cutaneous Histiocytic Sarcoma: A Rare Case.
Cureus
August 2025
Department of Pathology, Saint Savvas Anticancer Hospital of Athens, Athens, GRC.
Histiocytic sarcoma is a rare malignancy composed of neoplastic cells that resemble macrophages in morphology and immunoprofile. It manifests in lymph nodes or extranodal sites, with the majority occurring in the gastrointestinal tract, central nervous system, spleen, skin, and soft tissues. Clinical manifestations depend on organ involvement, with systemic symptoms, including fever, fatigue, night sweats, weight loss, and weakness.
View Article and Find Full Text PDFFDA approves Veozah (Fezolinetant) for menopausal symptoms: a new nonhormonal option.
Ann Med Surg (Lond)
September 2025
Department of Medicine, Georgia State University, Atlanta, USA.
Menopausal vasomotor symptoms (VMS), such as hot flashes and night sweats, significantly impact the quality of life for many women. While hormone therapy remains a standard treatment, it is not suitable for all patients due to contraindications, safety concerns, or personal preferences. Fezolinetant (Veozah), a non-hormonal neurokinin-3 receptor (NK3R) antagonist, has emerged as a novel alternative for managing moderate to severe menopausal VMS.
View Article and Find Full Text PDF